Sponsored By

The partnership outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility.

MDDI Staff

January 18, 2023

1 Min Read
IMG_2023-1-18-171654.jpg
Image courtesy of Yuji Sakai/ Getty Images

Ilika and Cirtec Medical announced they would be broadening their commercialization and manufacturing partnership. The two companies have entered into a memorandum of understanding , which outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in Lowell, MA.

This will reinforce Cirtec’s ongoing activities in system level miniaturization for the medical device industry. Ilika will focus on advanced technology development and IP licensing in support of Cirtec’s manufacturing and commercialization activities.

“Our partnership with Cirtec reinforces a pathway towards commercialization of our Stereax battery technology,” commented Graeme Purdy, Ilika Chief Executive Officer, adding, “Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialization in the medical device industry to our partnership.”

“With over 20 years of experience in the design, development, and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets,” said Brian Highley, Cirtec Medical CEO.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like